On 22 January, Amgen announced the positive results of the Phase IIIb LIBERTY trial for Aimovig (erenumab) for the treatment of episodic migraine. The trial was carried out in 246 episodic migraineurs who had failed […]
In October 2017, the Rare Genomics Institute (RG) announced the launch of the 2018 BeHEARD (Helping Empower and Accelerate Research Discoveries) science challenge. The competition, which has been hosted annually since 2012, aims to advance […]
The influenza season now is in full swing in the Northern Hemisphere, with four strains of the disease in circulation this year, as is typical. In Europe, however, the most frequently administered jabs, known as […]
Earlier this week, Celgene announced a $9 billion cash buyout of the remaining 90% stake in Juno Therapeutics that it does not already own. This news signals a significant, albeit risky, push for Celgene in […]
The team’s findings, published on 17 January in the journal Nature, shed new light on how the hormone, named ‘alpha-Klotho’ after the Greek goddess who spins the thread of life, transmits a signal that slows […]